For the quarter ending 2026-03-31, RXO had $4M increase in cash & cash equivalents over the period. -$24M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -36 | -46 | -14 | -40 |
| Depreciation and amortization expense | 26 | 28 | 26 | 62 |
| Stock compensation expense | 7 | 7 | 8 | 14 |
| Deferred tax benefit | -15 | -6 | -2 | -13 |
| Deemed non-pro rata distribution | - | 0 | -4 | 4 |
| Impairment of operating lease assets | 4 | 1 | 3 | - |
| Goodwill impairment | - | 12 | - | - |
| Debt extinguishment loss | -11 | - | - | - |
| Other | -2 | -4 | -1 | -6 |
| Accounts receivable | -8 | 125 | 39 | -159 |
| Other current assets and other long-term assets | 27 | 1 | -27 | 7 |
| Accounts payable | 49 | 58 | 19 | -93 |
| Accrued expenses, other current liabilities and other long-term liabilities | -36 | 75 | -2 | -71 |
| Net cash used in operating activities | -7 | 7 | 23 | 21 |
| Proceeds from sale of property and equipment | - | 1 | 0 | 1 |
| Payment for purchases of property and equipment | 17 | 16 | 14 | 29 |
| Business acquisition, net of cash acquired | 0 | 0 | 0 | 10 |
| Other | - | 0 | -1 | 5 |
| Net cash used in investing activities | -17 | -15 | -13 | -43 |
| Proceeds from borrowings on revolving credit facilities | 325 | 95 | 210 | 261 |
| Repayment of borrowings on revolving credit facilities | 324 | 95 | 211 | 227 |
| Proceeds from issuance of common stock and pre-funded warrants | - | 0 | 0 | - |
| Proceeds from issuance of debt | 400 | - | - | - |
| Payment for equity issuance costs | - | 1 | - | - |
| Repurchase of debt | 362 | - | - | - |
| Repayment of debt and finance leases | 1 | 1 | 0 | 1 |
| Payment for equity issuance costs | - | - | 0 | -1 |
| Payment for debt issuance costs | 8 | 0 | - | - |
| Payment for tax withholdings related to vesting of stock compensation awards | 2 | -1 | 2 | 18 |
| Repurchase of common stock | - | 0 | - | - |
| Other | 0 | 0 | 0 | -10 |
| Net cash provided by financing activities | 28 | 0 | -3 | 4 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 0 | 0 | 0 | 2 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 4 | -8 | 7 | -16 |
| Cash, cash equivalents, and restricted cash, beginning of period | 18 | 26 | 35 | - |
| Cash, cash equivalents, and restricted cash, end of period | 22 | 18 | 26 | - |
RXO, Inc. (RXO)
RXO, Inc. (RXO)